Mirae Asset Global Investments Co., Ltd. Xencor Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Xencor Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,841 shares of XNCR stock, worth $38,384. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,841
Previous 33,942
94.58%
Holding current value
$38,384
Previous $751,000
95.47%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding XNCR
# of Institutions
204Shares Held
63.1MCall Options Held
3.9KPut Options Held
3K-
Black Rock Inc. New York, NY11.1MShares$232 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.12MShares$190 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$146 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$111 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$82.6 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.24B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...